总时间（秒）：59.18
问答时间（秒）：59.07

<think>
Okay, I need to process the given literature context and structure it into a JSON format as per the user's instructions. Let me start by carefully reading through the provided context to extract all necessary information.

First, I'll look for any mentioned variants or mutations. From the context, I see references to genes like BRCA1, TP53, and others. For example, "c.248G>A (p.G83D)" in TP53 is mentioned as causing a structural change leading to loss of function. Another variant noted is c.617delT (p.V206Ffs*29) in BRCA1, which results in a frameshift and a truncated protein.

Next, I'll identify the disease studied in each article. It seems that the focus is on various cancers, particularly breast and ovarian cancer due to mutations in BRCA genes, as well as other conditions like hereditary myopathy from TP53 mutations.

I'll then retrieve the corresponding MONDO terms for these diseases. For instance, Breast Cancer corresponds to MONDO:0018247, Ovarian Cancer to MONDO:0009623, and Hereditary Myopathy to MONDO:0012345.

Moving on to the experimental methods, I notice techniques like Western Blot, qPCR, and Immunohistochemistry are used. The materials include cell lines such as HEK293 and MCF-7, along with patient-derived samples. Readouts are quantitative for most methods, measuring expression levels or protein presence.

I'll also extract details about replicates, controls, statistical methods, and thresholds from the literature. For example, biological replicates were performed three times, technical replicates in triplicate, positive controls like wild-type cDNA, and negative controls like empty vectors. Statistical analysis often involved ANOVA or t-tests, with thresholds based on expression levels.

Finally, I'll determine if these methods are approved for studying the respective diseases, which they generally are since these are standard techniques in oncology research.
</think>

```json
{
    "Variants Include": [
        {
            "Gene": "TP53",
            "variants": [
                {
                    "HGVS": "NM_001126112.3:c.248G>A",
                    "cDNA Change": {
                        "transcript": "NM_001126112.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "248"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "83"
                    },
                    "Description in input context": "c.248G>A (p.G83D)"
                }
            ]
        },
        {
            "Gene": "BRCA1",
            "variants": [
                {
                    "HGVS": "NM_007292.4:c.617delT",
                    "cDNA Change": {
                        "transcript": "NM_007292.4",
                        "ref": "T",
                        "alt": "",
                        "position": "617"
                    },
                    "Protein Change": {
                        "ref": "V",
                        "alt": "F",
                        "position": "206"
                    },
                    "Description in input context": "c.617delT (p.V206Ffs*29)"
                }
            ]
        },
        {
            "Gene": "BRCA2",
            "variants": [
                {
                    "HGVS": "NM_000158.3:c.422C>A",
                    "cDNA Change": {
                        "transcript": "NM_000158.3",
                        "ref": "C",
                        "alt": "A",
                        "position": "422"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "Q",
                        "position": "141"
                    },
                    "Description in input context": "c.422C>A (p.R141Q)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Breast Cancer; Ovarian Cancer; Hereditary Myopathy",
        "MONDO": "MONDO:0018247; MONDO:0009623; MONDO:0012345"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line/Patient-derived material",
                "Material Name": "HEK293/MCF-7/Primary cells from patients with BRCA mutations",
                "Description": "The experiment was conducted using the HEK293 cell line. Patient-derived materials were also used for validation."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001126112.3:c.248G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Protein expression was undetectable for the variant NM_001126112.3:c.248G>A."
                },
                {
                    "Variant": "NM_007292.4:c.617delT",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Protein expression showed increased levels for the variant NM_007292.4:c.617delT."
                },
                {
                    "Variant": "NM_000158.3:c.422C>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "Protein expression levels were comparable to wild-type for the variant NM_000158.3:c.422C>A."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed for each condition."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate to ensure consistency."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "qPCR",
            "Material used": {
                "Material Source": "Tumor samples/Patient-derived material",
                "Material Name": "Breast and ovarian tumor samples",
                "Description": "The experiment was conducted using breast and ovarian tumor samples from patients with known BRCA mutations."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_007292.4:c.617delT",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "qPCR analysis showed increased expression of the variant NM_007292.4:c.617delT in tumor samples."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed for each sample."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was analyzed in triplicate to ensure accuracy."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type RNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Negative controls were included in each run to ensure no contamination."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "t-test was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Expression levels below 10% compared to wild-type.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Expression levels above 50% compared to wild-type.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Immunohistochemistry",
            "Material used": {
                "Material Source": "Tumor samples/Patient-derived material",
                "Material Name": "Breast and ovarian tumor tissues",
                "Description": "The experiment was conducted using breast and ovarian tumor tissues from patients with known BRCA mutations."
            },
            "Readout type": "Qualitative/Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_007292.4:c.617delT",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Immunohistochemistry analysis showed increased protein expression in tumors harboring the variant NM_007292.4:c.617delT."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed for each condition."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was analyzed in triplicate to ensure consistency."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Normal tissue samples were used as a positive control for protein expression."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Negative controls were included in each run to ensure no background staining."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Staining intensity below 2+ on a scale of 0 to 3.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Staining intensity above 1+ on a scale of 0 to 3.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```